Type 1 diabetes: open trials in Brazil

• NCT07222137

  A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Freire Pesquisa Clinica, Belo Horizonte · Centro de Diabetes Curitiba, Curitiba · Hospital Universitario Walter Cantidio, Fortaleza · Cendi - Endocrinologia e Diabetes, Goiânia · Centro de Pesquisa Clínica de Marília - CPCLIM, Marília · Universidade Federal Do Rio de Janeiro, Rio de Janeiro · CPCLIN, São Paulo · IBTED - Tecnologia e Educação em Diabetes, São Paulo · Instituto de Pesquisa Clinica, São Paulo · Hospital das Clinicas FMUSP, São Paulo

  Registry updated 2026-11-04

• NCT07222332

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Hospital Universitário Maria Aparecida Pedrossian, Campo Grande · Quanta Diagnóstico e Terapia, Curitiba · Centro de Diabetes Curitiba, Curitiba · Centro De Diabetes Metabolismo E Endocrinologia, Fortaleza · Cendi - Endocrinologia e Diabetes, Goiânia · Centro de Pesquisa Clínica de Marília - CPCLIM, Marília · Instituto da Crianca com Diabetes, Porto Alegre · Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) - HCFM -T, Ribeirão Preto · Universidade Federal Do Rio de Janeiro, Rio de Janeiro · Clínica Hepatogastro JK, São Paulo · Hospital das Clinicas FMUSP, São Paulo · IBTED - Tecnologia e Educação em Diabetes, São Paulo · Instituto de Pesquisa Clinica, São Paulo · CPCLIN, São Paulo · CEDOES, Vitória

  Registry updated 2026-11-04

• NCT07784725

  A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  Trial Treatment · Phase 3 · AstraZeneca

  Belo Horizonte · Brasília · Campinas · Curitiba · Natal · Porto Alegre · Rio de Janeiro · São José dos Campos · São Paulo

  Registry updated 2026-10-30

• NCT07088068

  A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  Trial Treatment · Phase 3 · Sanofi

  Centro de Diabetes Curitiba- Site Number : 0760006, Curitiba · Hospital Universitario Walter Cantidio- Site Number : 0760009, Fortaleza · Centro de Pesquisa Clínica de Marília - CPCLIM- Site Number : 0760002, Marília · Hospital Universitario Clementino Fraga Filho- Site Number : 0760008, Rio de Janeiro · Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760012, São Paulo · Centro de Pesquisas Clínicas - São Paulo- Site Number : 0760011, São Paulo · Hospital Israelita Albert Einstein- Site Number : 0760001, São Paulo

  Registry updated 2026-10-13

• NCT07776509

  A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  Trial Treatment · Phase 3 · AstraZeneca

  Belo Horizonte · Campinas · São Paulo

  Registry updated 2026-09-25

• NCT07797335

  AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Instituto de Ciências Farmacêuticas de Estudos e Pesquisas, Aparecida de Goiânia · Hospital Universitário Joao de Barros Barreto - UFPA, Belém · Associação Lar São Francisco de Assis na Providência de Deus - Bragança Paulista, Bragança Paulista · CECAP - Centro de Cardiologia Clínica e Pesquisa Dra. Juliana Souza, Brasília · Instituto de Pesquisa Clínica de Campinas, Campinas · i9 Pesquisas Clínicas, Campinas · Centro de Diabetes Curitiba, Curitiba · Instituto de Ensino e Pesquisa Clínica do Ceará Ltda, Fortaleza · Hospital das Clinicas da Universidade Federal de Goias, Goiânia · CPHosp Manaus Medicina, Ensino e Pesquisa LTDA, Manaus · Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto, Sao Jose Rio Preto · Instituto do Coração - HCFMUSP, São Paulo · CPQuali Pesquisa Clínica Ltda, São Paulo · CEPIC - Centro Paulista de Investigação Clínica, São Paulo · Instituto de Pesquisa Clinica (IPEC), São Paulo · Eurolatino Medical Research Center, Uberlândia · Lóbus Centro de Pesquisa Clínica LTDA, Volta Redonda

  Registry updated 2026-09-01

• NCT07518121

  A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil

  Trial Treatment · Phase 1 · Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

  A2Z Clinical Centro Avançado de Pesquisa Clínica LTDA, Valinhos

  Registry updated 2026-04-08

• NCT07150052

  Efficacy and Safety of an Artificial Intelligence Tool for Carbohydrate Counting (Tiabete) in Children and Adults With Type 1 Diabetes Mellitus

  Trial Treatment · University of Sao Paulo

  University of Sao Paulo, São Paulo

  Registry updated 2025-09-02

• NCT06934707

  Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes

  Trial Treatment · Hospital de Clinicas de Porto Alegre

  Hospital de Clinicas de Porto Alegre, Porto Alegre

  Registry updated 2025-04-18

• NCT06764069

  Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor

  Trial Treatment · Glucotrack

  Instituto do Coração - InCor, São Paulo

  Registry updated 2025-01-08

All Type 1 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error